| Financial Year |
March 31 2023 |
| Monetary Funds |
241,416,198.05 |
| Held-for-trading Financial Assets |
100,000,000.00 |
| Notes Receivable |
41,392,731.48 |
| Accounts Receivable |
412,051,713.74 |
| Advances to Suppliers |
5,328,993.25 |
| Other Receivables |
649,316.25 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
190,349,941.53 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
2,713,806.43 |
| Total Current Assets |
1,074,734,877.83 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
292,065,119.49 |
| Under-construction Projects |
234,810,118.87 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
54,477,099.51 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
4,273,282.36 |
| Deferred Income Tax Assets |
11,673,661.78 |
| Other Non-Current Assets |
88,694,035.69 |
| Sub-Total of Non-Current Assets |
687,439,431.30 |
| Total Assets |
1,762,174,309.13 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
201,755,502.35 |
| Accounts Payable |
142,538,582.54 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
3,132,576.37 |
| Taxes Payable |
425,345.83 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
1,893,753.34 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,571,988.29 |
| Other Current Liabilities |
36,556,282.47 |
| Sub-Total of Current Liabilities |
388,609,516.67 |
| Long-term Loans |
-- |
| Bonds Payable |
274,667,412.83 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
2,843,634.53 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
293,992,039.97 |
| Total Liabilities |
682,601,556.64 |
| Paid-In Capital(Or Share Stock) |
100,000,202.00 |
| Capital Surplus |
517,815,000.34 |
| Surplus Reserve |
42,251,660.02 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
330,639,385.62 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,079,572,752.49 |
| Owner's Equity（Stockholder's Equity） |
1,079,572,752.49 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,762,174,309.13 |
